Sponsors

Search for a sponsor by name or class, and view related trials.

Boehringer Ingelheim Pharmaceuticals - Industry

Related Trials

Title Role Status
Long-term, Open-label Follow-up Treatment of Patients With A-fib Who Have Been Previously Treated With BIBR 1048 Lead Sponsor Terminated_status_icon
Headache Study to Compare Aggrenox Full Dose and Reduced Dose Lead Sponsor Completed_status_icon
PETRO Stroke Prevention in Patients With AF by Treatment With Dabigatran, With and Without Aspirin, Compared to Warfarin Lead Sponsor Completed_status_icon
EAGLE - Multicenter Study of the European Assessment Group for Lysis in the Eye Collaborator Terminated_status_icon
Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo. Lead Sponsor Completed_status_icon
Echoplanar Imaging Thrombolysis Evaluation Trial (EPITHET) Collaborator Active_not_recruiting_status_icon
Rt-PA in the Treatment of Acute Ischemic Stroke Lead Sponsor Completed_status_icon
PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes Lead Sponsor Completed_status_icon
JASAP: Japanese Aggrenox Stroke Prevention vs. Aspirin Programme Lead Sponsor Completed_status_icon
Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate Lead Sponsor Completed_status_icon
EARLY 3-months Aggrenox Treatment Started Within 24 Hrs of Ischemic Stroke Onset vs. After One Week 100 mg ASA Lead Sponsor Completed_status_icon
GLORIA-AF Registry Program - Second and Third Phases Lead Sponsor Recruiting_status_icon
A Prospective, Open Label Study Evaluating Two Management Strategies on Gastrointestinal Symptoms in Patients Newly on Treatment With Pradaxa for the Prevention of Stroke and Systemic Embolism With Non-valvular Atrial Fibrillation Lead Sponsor Recruiting_status_icon